Background: To date, the 12-lead electrocardiogram (ECG) is the gold standard for cardiological diagnosis in clinical settings. With the advancements in technology, a growing number of smartphone apps and gadgets for recording, visualizing, and evaluating physical performance as well as health data is available. Although this new smart technology is innovative and time- and cost-efficient, less is known about its diagnostic accuracy and reliability.

Objective: This study aimed to examine the agreement between the mobile single-lead ECG measurements of the Kardia Mobile App and the Apple Watch 4 compared to the 12-lead gold standard ECG in healthy adults under laboratory conditions. Furthermore, it assessed whether the measurement error of the devices increases with an increasing heart rate.

Methods: This study was designed as a prospective quasi-experimental 1-sample measurement, in which no randomization of the sampling was carried out. In total, ECGs at rest from 81 participants (average age 24.89, SD 8.58 years; n=58, 72% male) were recorded and statistically analyzed. Bland-Altman plots were created to graphically illustrate measurement differences. To analyze the agreement between the single-lead ECGs and the 12-lead ECG, Pearson correlation coefficient (r) and Lin concordance correlation coefficient (CCC) were calculated.

Results: The results showed a higher agreement for the Apple Watch (mean deviation QT: 6.85%; QT interval corrected for heart rate using Fridericia formula [QTcF]: 7.43%) than Kardia Mobile (mean deviation QT: 9.53%; QTcF: 9.78%) even if both tend to underestimate QT and QTcF intervals. For Kardia Mobile, the QT and QTcF intervals correlated significantly with the gold standard (r=0.857 and r=0.727; P<.001). CCC corresponded to an almost complete heuristic agreement for the QT interval (0.835), whereas the QTcF interval was in the range of strong agreement (0.682). Further, for the Apple Watch, Pearson correlations were highly significant and in the range of a large effect (r=0.793 and r=0.649; P<.001). CCC corresponded to a strong heuristic agreement for both the QT (0.779) and QTcF (0.615) intervals. A small negative correlation between the measurement error and increasing heart rate could be found of each the devices and the reference.

Conclusions: Smart technology seems to be a promising and reliable approach for nonclinical health monitoring. Further research is needed to broaden the evidence regarding its validity and usability in different target groups.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10704323PMC
http://dx.doi.org/10.2196/50701DOI Listing

Publication Analysis

Top Keywords

kardia mobile
16
apple watch
12
gold standard
12
diagnostic accuracy
8
mobile app
8
app apple
8
correlation coefficient
8
qtcf intervals
8
mobile
5
accuracy single-lead
4

Similar Publications

Home Sotalol Initiation for the Management of Atrial and Ventricular Arrhythmias Using Remote Electrocardiographic Monitoring.

JACC Clin Electrophysiol

November 2024

Section of Cardiac Electrophysiology, Department of Cardiology, OhioHealth Heart and Vascular Physicians, Riverside Methodist Hospital, Columbus, Ohio, USA.

Background: Sotalol is a class III antiarrhythmic drug used for the management of patients with atrial fibrillation to maintain sinus rhythm. Sotalol-induced QT interval prolongation can be proarrhythmic and is conventionally initiated in an inpatient setting where routine electrocardiographic (ECG) monitoring is available while sotalol reaches the steady state. The emergence of cellular-compatible home ECG devices, such as AliveCor's Kardia Mobile 6L, which offers 6-lead ECG, has made it possible to accurately measure QT intervals outside the hospital.

View Article and Find Full Text PDF

Prevalence of atrial fibrillation based on tertiary hospital survey in Indonesia: A smartphone-based diagnosis.

J Arrhythm

October 2024

Wahidin Sudirohusodo Hospital, Makassar, South Sulawesi, and Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Hasanuddin Makassar Indonesia.

Article Synopsis
  • - The study investigates the prevalence of atrial fibrillation (AF) in various Indonesian cities using a smartphone-enabled electrocardiography device.
  • - Conducted between January 2018 and July 2019, the research involved 9,773 participants, finding AF prevalence rates of 3.2% via the device and 3.5% confirmed by cardiologists.
  • - Most participants (56%) had a low risk for stroke; common risk factors among those with AF included heart failure (50%) and hypertension (22.9%).
View Article and Find Full Text PDF
Article Synopsis
  • Atrial fibrillation (AFib) detection using mobile ECG devices has potential, but existing algorithms often struggle to work well across different datasets and devices, affecting their real-world use.!* -
  • This study created a new voting algorithm based on random forest technology that combines six different AFib detection algorithms, which was trained on an AliveCor dataset and tested against other datasets, including Apple Watch data.!* -
  • The new algorithm showed superior performance across various metrics compared to individual algorithms, proving to be more robust and effective in detecting AFib, and highlighting the benefits of using combined crowd-sourced strategies for better cardiac monitoring in wearable tech.!*
View Article and Find Full Text PDF

KardiaMobile 6L versus 12-lead ECG: Effects on clinic utilization time.

J Cardiovasc Electrophysiol

August 2024

Division of Cardiology, Northwestern Medicine, Chicago, Illinois, USA.

Article Synopsis
  • - The study aimed to determine if the KardiaMobile 6L ECG technology could reduce the time needed for ECG collection compared to the standard 12L ECG, without losing data quality.
  • - Conducted with 100 patients at an electrophysiology clinic, the study found that the average room utilization time was significantly shorter for the KardiaMobile 6L group (7.27 min) compared to the 12L group (10.33 min).
  • - Although 16% of the 6L visits required an additional standard 12L ECG, the overall findings indicate that KardiaMobile 6L effectively decreases clinic utilization time.
View Article and Find Full Text PDF

Background: Single-lead, smartphone-based mobile electrocardiograms (ECGs) have the potential to provide a noninvasive, rapid, and cost-effective means of screening for atrial fibrillation (AFib) in outpatient settings. AFib has been associated with various comorbid diseases that prompt further investigation and screening methodologies for at-risk populations. A simple 30-second sinus rhythm strip from the KardiaMobile ECG (AliveCor) can provide an effective screen for cardiac rhythm abnormalities.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!